| Renal Transplant |
38.4% |
| Product Used For Unknown Indication |
12.1% |
| Immunosuppression |
11.1% |
| Rheumatoid Arthritis |
7.1% |
| Prophylaxis Against Renal Transplant Rejection |
5.1% |
| Acute Graft Versus Host Disease |
4.0% |
| Pancreatic Carcinoma |
3.0% |
| Graft Versus Host Disease |
2.0% |
| Haemolytic Uraemic Syndrome |
2.0% |
| Immunosuppressant Drug Therapy |
2.0% |
| Nocardiosis |
2.0% |
| Renal Osteodystrophy |
2.0% |
| Transient Ischaemic Attack |
2.0% |
| Erectile Dysfunction |
1.0% |
| Focal Segmental Glomerulosclerosis |
1.0% |
| Gastritis |
1.0% |
| Hyperchlorhydria |
1.0% |
| Organ Transplant |
1.0% |
| Pain |
1.0% |
| Systemic Lupus Erythematosus |
1.0% |
